Journal: Heart and vessels

Article Title: Impact of combined lipid lowering and blood pressure control on coronary plaque: myocardial ischemia treated by percutaneous coronary intervention and plaque regression by lipid lowering and blood pressure controlling assessed by intravascular ultrasonography (MILLION) study.

PMID/MRN: 27798731

Publication Date: 2016-Oct-31

Abstract:

The aim of the study was to elucidate the aggressive reduction of both low-density lipoprotein cholesterol (LDL-C) and blood pressure (BP) reduced coronary atherosclerotic plaque volume compared with a standard treatment of LDL-C and BP in Japanese patients with coronary artery disease (CAD). This study is a prospective, randomized, and open-labelled with a blind-endpoint evaluation study. A total of 97 patients (81 men, mean age 62.0ʱÊ9.6) with CAD undergoing intravascular ultrasonography (IVUS)-guided percutaneous coronary intervention (PCI) were randomized, and 68 patients had IVUS examinations at baseline and at 18-24Êmonths follow-up. Patients were randomly assigned to standard or aggressive strategies targeting LDL-C and a BP of 100Êmg/dL and 140/90ÊmmHg vs. 70Êmg/dL and 120/70ÊmmHg, respectively. The primary endpoint was the percent change in coronary plaque volume. Both standard and aggressive strategies succeeded to achieve target levels of LDL-C and BP; 74.9ʱÊ14.7 vs. 63.7ʱÊ11.9Êmg/dL (NS) and 124.1ʱÊ9.4/75.8ʱÊ7.7 vs. 113.6ʱÊ9.6/65.8ʱÊ9.4ÊmmHg (systolic BP; NS, diastolic BP; pÊ<Ê0.05), respectively. Both groups showed a significant reduction in the coronary plaque volume of -9.4ʱÊ10.7% and -8.7ʱÊ8.6% (NS) in standard and aggressive therapies, respectively. Both standard and aggressive intervention significantly regressed coronary plaque volume by the same degree, suggesting the importance of simultaneous reductions of LDL-C and BP for prevention of CAD.